SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $5,914,000 | +18.3% | 30,964 | +1.9% | 0.04% | +12.9% |
Q2 2020 | $4,999,000 | +31.3% | 30,400 | -7.9% | 0.03% | +10.7% |
Q1 2020 | $3,806,000 | -12.9% | 33,009 | -13.7% | 0.03% | +16.7% |
Q4 2019 | $4,369,000 | -0.4% | 38,247 | -33.7% | 0.02% | 0.0% |
Q3 2019 | $4,386,000 | -3.0% | 57,702 | -14.1% | 0.02% | -4.0% |
Q2 2019 | $4,523,000 | +47.8% | 67,185 | +57.7% | 0.02% | +47.1% |
Q1 2019 | $3,060,000 | +104.8% | 42,616 | +59.4% | 0.02% | +88.9% |
Q4 2018 | $1,494,000 | -26.7% | 26,731 | +2.6% | 0.01% | -18.2% |
Q3 2018 | $2,037,000 | -6.9% | 26,045 | -20.9% | 0.01% | -8.3% |
Q2 2018 | $2,187,000 | +28.5% | 32,933 | 0.0% | 0.01% | +20.0% |
Q1 2018 | $1,702,000 | -3.4% | 32,933 | 0.0% | 0.01% | +11.1% |
Q4 2017 | $1,762,000 | -37.8% | 32,933 | -36.7% | 0.01% | -43.8% |
Q3 2017 | $2,831,000 | -6.8% | 52,033 | -8.8% | 0.02% | -11.1% |
Q2 2017 | $3,038,000 | -15.3% | 57,033 | +0.4% | 0.02% | -14.3% |
Q1 2017 | $3,585,000 | +183.0% | 56,833 | +139.5% | 0.02% | +162.5% |
Q4 2016 | $1,267,000 | +271.6% | 23,733 | +270.8% | 0.01% | +300.0% |
Q3 2016 | $341,000 | -96.0% | 6,400 | -97.0% | 0.00% | -96.7% |
Q4 2013 | $8,579,000 | +61.3% | 213,257 | +76.2% | 0.06% | +46.3% |
Q3 2013 | $5,319,000 | +2222.7% | 121,057 | +1566.8% | 0.04% | +1950.0% |
Q2 2013 | $229,000 | – | 7,263 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |